EUCALIA

EUCALIA EBITDA per Share

The EBITDA per Share of EUCALIA (286A.T) as of Nov 5, 2026 is 66.19 JPY. In the previous year, EBITDA per Share was 64.80 JPY — a change of 2.14% (higher).

EBITDA per Share

66.19JPY

YoY

2.14%

Last updated:

EBITDA per Share of EUCALIA is 2025 66.19 JPY. EBITDA per Share of EUCALIA was 2024 64.80 JPY. It decreases by 2.14% higher compared to the previous year.

The EUCALIA EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2022
24.18 JPY
Jan 1, 2023
53.08 JPY
Jan 1, 2024
64.80 JPY
Jan 1, 2025
66.19 JPY
The EUCALIA EBITDA per Share history
YEAREBITDA per ShareYoY
66.19JPY+2.14%
64.80JPY+22.10%
53.08JPY+119.47%
24.18JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EUCALIA Stock analysis

What does EUCALIA do? EUCALIA Inc generates revenue through three core business segments. The Medical Management Comprehensive Support Business offers management consulting, personnel recruitment, DX support, and fundraising for medical corporations. The Senior Related Business provides nursing care facility operations, admission consultation, and facility introduction services. The Highly Controlled Medical Device Business sells contact lenses and supplies pharmaceutical companies with treatment progress data analysis and sales activity support. Subsidiaries contribute through venture investment, brain checkup services, and real estate transactions. Pharmaceutical companies purchase treatment progress data analysis and sales activity support services. Medical corporations utilize management consulting, recruitment, DX, and fundraising support. Nursing care facility operators and potential residents engage with senior care services. Venture investments and real estate transactions are handled by subsidiaries, supporting the company's broader financial ecosystem. The company's revenue streams are diversified across healthcare support, senior care services, and medical device manufacturing. Medical corporations, pharmaceutical firms, and nursing care facility stakeholders form the primary customer base. Subsidiary activities in venture investment and real estate complement the core business model without direct revenue generation from these segments. EUCALIA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EUCALIA stock

EBITDA per Share of EUCALIA is 66.19 JPY in 2025.

EBITDA per Share of EUCALIA changed from 64.80 JPY to 66.19 JPY, representing a 2.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share EUCALIA since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — EUCALIA

All Key Metrics — EUCALIA